| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taurine (2-aminoethanesulfonic acid) is a sulfur-containing “amino acid–like” molecule (not incorporated into proteins). It’s abundant in many tissues and is best thought of as a homeostatic modulator rather than a direct cytotoxin.Core biology themes: -Osmoregulation / membrane stabilization -Mitochondrial support + anti-oxidant tone (indirect) -Calcium handling modulation -Anti-inflammatory signaling (context-dependent) -Bile acid conjugation (tauroursodeoxycholic-type physiology, but taurine itself is a conjugating substrate) Cancer relevance (preclinical/adjunct framing): -Often discussed as protective (normal-tissue protection) and stress-modulating, not a primary anti-cancer agent. -May influence redox balance, ER stress, and inflammation, which can indirectly affect tumor biology or therapy tolerance (model-dependent). -ROS axis: tends to reduce oxidative injury (indirect) -NRF2: sometimes reported as part of antioxidant adaptation, but not a “core direct target”Amino acid that benefits the heart, brain and immune system. Taurine, an organic compound containing sulfur in its chemical structure, possesses anti-inflammatory, anti-oxidant, and various physiological functions within the cardiovascular, kidney, endocrine, and immune systems. Also an LDH inhibitor -Neuroprotection: helps protect neurons against excitotoxicity (e.g., glutamate damage) and ROS stress. -Anti-oxidative action: scavenges ROS, reducing oxidative stress seen in AD brains. -Anti-inflammatory -Calcium homeostasis Helps maintain intracellular calcium balance, disrupted in AD. -Amyloid-beta toxicity May reduce Aβ-induced neurotoxicity and cell death in vitro. -Tau pathology: possible reduction of tau hyperphosphorylation. -Memory and cognition may improve learning and memory.
Time-Scale Flag (TSF): P / R / G
Alzheimer’s Disease (AD)-Oriented Time-Scale Flagged Pathway Table
Time-Scale Flag (TSF): P / R / G
|
| Source: |
| Type: |
| Vimentin, a major constituent of the intermediate filament family of proteins, is ubiquitously expressed in normal mesenchymal cells and is known to maintain cellular integrity and provide resistance against stress. Vimentin is overexpressed in various epithelial cancers, including prostate cancer, gastrointestinal tumors, tumors of the central nervous system, breast cancer, malignant melanoma, and lung cancer. Vimentin’s overexpression in cancer correlates well with accelerated tumor growth, invasion, and poor prognosis; however, the role of vimentin in cancer progression remains obscure. In many epithelial-derived tumors (carcinomas), elevated Vimentin expression is often observed in cancer cells that have undergone EMT. This upregulation is characteristic of a shift toward a mesenchymal state, which is associated with reduced cell–cell adhesion and increased motility. Vimentin expression is also noted in the tumor stroma, reflecting the presence and activation of mesenchymal cells such as cancer-associated fibroblasts (CAFs). This dual expression can contribute to the remodeling of the tumor microenvironment. The degree of Vimentin expression may vary depending on the tumor type, grade, and stage. More aggressive and advanced tumors tend to show higher levels of Vimentin expression. High Vimentin expression has been correlated with poor clinical outcomes in several cancers, including breast, colorectal, prostate, and lung cancers. Elevated Vimentin levels are typically associated with higher tumor grade, increased invasiveness, enhanced metastatic potential, and a greater risk of recurrence. As a component of the EMT signature, high Vimentin expression can serve as an indicator of a more aggressive tumor phenotype and is often associated with reduced overall survival. - vimentin up-regulation is often used as a marker of EMT in cancer |
| 1137- | Taur, | Taurine Attenuates Epithelial-Mesenchymal Transition-Related Genes in Human Prostate Cancer Cells |
| - | in-vitro, | Pca, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:158 Target#:336 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid